Baxter Healthcare Corporation vs PHILIPS HEADQUARTERS CAMBRIDGE: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 208 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for PHILIPS HEADQUARTERS CAMBRIDGE.

Baxter Healthcare Corporation: 0 warning letters, 208 recalls, 0 approval records, 0 Form 483s.

PHILIPS HEADQUARTERS CAMBRIDGE: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

PHILIPS HEADQUARTERS CAMBRIDGE — Warning letters0

Baxter Healthcare Corporation — Recalls208

PHILIPS HEADQUARTERS CAMBRIDGE — Recalls4

Baxter Healthcare Corporation — Approval records0

PHILIPS HEADQUARTERS CAMBRIDGE — Approval records0

Baxter Healthcare Corporation — Form 483s0

PHILIPS HEADQUARTERS CAMBRIDGE — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: July 8, 2026

Full history →

PHILIPS HEADQUARTERS CAMBRIDGE

Most recent FDA action: May 31, 2023

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs PHILIPS HEADQUARTERS CAMBRIDGE: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-philips-headquarters-cambridge

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗